Stay updated on Durvalumab & Tremelimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab & Tremelimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab & Tremelimumab in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Publications From PubMed section wording was updated to indicate automatic filling from PubMed. Revision labels were updated from v3.2.0 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-25T10:33:16.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page no longer displays the government funding/operational status notice; core study content and details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-18T06:51:14.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The location entry changed from 'Tainan City, Taiwan, 704' to 'Tainan, Taiwan, 704' in the study's Locations list. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-11T02:12:19.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The study details content appears unchanged between versions; there are no additions or deletions to arms, criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T20:41:48.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and the new government-operating-status notice; the old v3.1.0 tag was removed.
    Difference
    2%
    Check dated 2025-10-06T05:09:52.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.0%
    Check dated 2025-09-29T02:58:00.000Z thumbnail image

Stay in the know with updates to Durvalumab & Tremelimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab & Tremelimumab in NSCLC Clinical Trial page.